ZA200309791B - Pirenzepine opthalmic gel. - Google Patents

Pirenzepine opthalmic gel.

Info

Publication number
ZA200309791B
ZA200309791B ZA200309791A ZA200309791A ZA200309791B ZA 200309791 B ZA200309791 B ZA 200309791B ZA 200309791 A ZA200309791 A ZA 200309791A ZA 200309791 A ZA200309791 A ZA 200309791A ZA 200309791 B ZA200309791 B ZA 200309791B
Authority
ZA
South Africa
Prior art keywords
pirenzepine
opthalmic
gel
pirenzepine opthalmic
opthalmic gel
Prior art date
Application number
ZA200309791A
Other languages
English (en)
Inventor
Harun Takruri
Original Assignee
Valley Forge Pharmaceuticals I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valley Forge Pharmaceuticals I filed Critical Valley Forge Pharmaceuticals I
Publication of ZA200309791B publication Critical patent/ZA200309791B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200309791A 2001-05-25 2003-12-18 Pirenzepine opthalmic gel. ZA200309791B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29373101P 2001-05-25 2001-05-25

Publications (1)

Publication Number Publication Date
ZA200309791B true ZA200309791B (en) 2004-10-04

Family

ID=23130330

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200309791A ZA200309791B (en) 2001-05-25 2003-12-18 Pirenzepine opthalmic gel.

Country Status (17)

Country Link
US (2) US20040137069A1 (de)
EP (1) EP1397132A4 (de)
JP (1) JP2004531569A (de)
KR (1) KR20040018380A (de)
CN (1) CN1509172A (de)
BR (1) BR0210013A (de)
CA (1) CA2447562A1 (de)
EC (1) ECSP044862A (de)
HU (1) HUP0304071A2 (de)
IL (1) IL158904A0 (de)
MX (1) MXPA03010655A (de)
NO (1) NO20035224D0 (de)
NZ (1) NZ529615A (de)
PL (1) PL366924A1 (de)
RU (1) RU2297831C2 (de)
WO (1) WO2002096418A1 (de)
ZA (1) ZA200309791B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8039464B2 (en) * 2004-07-16 2011-10-18 Proteosys Ag Muscarinic antagonists with PARP and SIR modulating activity as agents for inflammatory diseases
JP4963359B2 (ja) * 2005-01-12 2012-06-27 ロート製薬株式会社 眼局所適用製剤
JP2010514517A (ja) * 2006-12-26 2010-05-06 キューエルティー プラグ デリバリー，インク． 視覚欠損の抑制のための薬物送達インプラント
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (de) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited Biologisch erodierbares Patch
MX2010002616A (es) 2007-09-07 2010-08-04 Qlt Plug Delivery Inc Nucleos de farmaco para la liberacion sostenida de agentes terapeuticos.
US8883214B2 (en) 2009-01-13 2014-11-11 The Regents Of The University Of California Implantable delivery vehicle for ocular delivery of muscarinic antagonists
DK2632468T3 (en) * 2010-10-25 2018-02-12 Univ Manitoba THERAPEUTIC COMPOSITIONS FOR SYMMETRIC DIABETIC POLYNEuropathy
HUE045467T2 (hu) 2011-03-14 2020-01-28 Drug Delivery Solutions Ltd Szemészeti készítmény
RU2635185C2 (ru) * 2013-12-17 2017-11-09 Иван Дмитриевич Захаров Фармацевтический препарат для профилактики и лечения прогрессирующей близорукости
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
WO2016172712A2 (en) 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
US11382909B2 (en) 2014-09-05 2022-07-12 Sydnexis, Inc. Ophthalmic composition
CN107847432A (zh) 2015-05-29 2018-03-27 西德奈克西斯公司 D2o稳定化的药物制剂
CN105663137A (zh) * 2016-01-14 2016-06-15 王真 哌仑西平在制备治疗脓毒症疾病的药物中的应用
EP4112055A1 (de) * 2016-05-25 2023-01-04 Singapore Health Services Pte Ltd Atropinhaltige wässrige zusammensetzung
CA3205816A1 (en) 2017-11-03 2019-05-09 Alcon Inc. Azabicyclo and diazepine derivatives for treating ocular disorders
EP3542788A1 (de) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat
MX2021011607A (es) * 2019-03-26 2021-12-10 Winsantor Inc Formulaciones topicas para el tratamiento de neuropatias perifericas.
AU2020290414A1 (en) * 2019-06-10 2021-12-02 Jenivision Inc. Methods and formulations for treating vision disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU188852B (en) * 1983-03-16 1986-05-28 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for producing thiazolidine derivatives active against gastric ulcer and intestinal ulcer
US4865599A (en) * 1986-08-18 1989-09-12 Houston Biotechnology, Inc. Ophthalmic compositions for treating nerve degeneration
CA1336490C (en) * 1988-06-03 1995-08-01 Paul Michael Iuvone Pharmacological treatment of ocular development
US5360801A (en) * 1989-06-21 1994-11-01 The Trustees Of The University Of Pennsylvania Pharmacological stimulation of eye growth
ATE147626T1 (de) * 1989-06-21 1997-02-15 Univ Pennsylvania Verwendung von pirenzepine, telenzepine oder o- methoxy -sila-hexocyclium zur herstellung eines medikaments zur behandlung und regulierung der augenentwicklung
US5122522A (en) * 1989-06-21 1992-06-16 The Trustees Of The University Of Pennsylvania Treatment and control of ocular development
US5055302A (en) * 1990-02-22 1991-10-08 Trustees Of The University Of Pennsylvania Neuropeptide control of ocular growth
US5461808A (en) * 1993-02-08 1995-10-31 Fritts; Robert W. Table top backlit display
US5385939A (en) * 1993-04-30 1995-01-31 The Trustees Of The University Of Pennsylvania GABA-ergic modulation of eye growth
US5461052A (en) * 1993-04-30 1995-10-24 The Trustees Of The University Of Pennsylvania Prevention of myopia by tricyclic compounds
US5516808A (en) * 1994-10-27 1996-05-14 Sawaya; Assad S. Topical cellulose pharmaceutical formulation
US5888493A (en) * 1996-12-05 1999-03-30 Sawaya; Assad S. Ophthalmic aqueous gel formulation and related methods
US6164282A (en) * 1999-01-27 2000-12-26 Allergan Sales, Inc. Methods for restoring and/or enhancing accommodation in pseudo phakia

Also Published As

Publication number Publication date
KR20040018380A (ko) 2004-03-03
IL158904A0 (en) 2004-05-12
RU2297831C2 (ru) 2007-04-27
CN1509172A (zh) 2004-06-30
CA2447562A1 (en) 2002-12-05
US20040137069A1 (en) 2004-07-15
ECSP044862A (es) 2004-03-23
PL366924A1 (en) 2005-02-07
NO20035224D0 (no) 2003-11-24
HUP0304071A2 (hu) 2004-04-28
NZ529615A (en) 2005-07-29
EP1397132A1 (de) 2004-03-17
RU2003136735A (ru) 2005-03-27
MXPA03010655A (es) 2007-06-22
US20060188576A1 (en) 2006-08-24
JP2004531569A (ja) 2004-10-14
WO2002096418A1 (en) 2002-12-05
BR0210013A (pt) 2004-08-10
EP1397132A4 (de) 2006-12-13

Similar Documents

Publication Publication Date Title
HU0401339D0 (en) Novel 4-anilinoquinoline-3-carboxamides
ZA200309791B (en) Pirenzepine opthalmic gel.
ZA200208561B (en) Hydraulischer druckverstarker.
AU2002357860A8 (en) Enzymes
MXPA01009037A (es) I-bet.
MXPA03005286A (es) METODO Y APARATO PARA SUPERVISAR PULSACION DE INSTALACION DE ORDEnA.
EP1391730A4 (de) Biopolymerhaltiges gel
MXPA03009073A (es) Altavoz.
EP1384783A4 (de) Neues maxizym
EG23036A (en) Novel pyrrolecarboxamides
GB0130151D0 (en) Glass covers
EP1428891A4 (de) Nedl-1, ein neues gen
AU149781S (en) Glass
GB0104440D0 (en) Novel genes
AU2003222146A8 (en) Novel l. x formolongo lilies
PL364076A1 (en) Novel pyridylmethylaminopyrimidines
GB0111709D0 (en) Novel pharmaceuticals
GB0109008D0 (en) Novel genes
GB0102946D0 (en) Enzyme
GB0115709D0 (en) Novel genes
GB0123418D0 (en) Mobile marketing
GB0107234D0 (en) Genes
GB0124037D0 (en) Genes
GB0130796D0 (en) Genes
GB0125757D0 (en) Genes